• Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts

    来源: Buzz FX / 13 1月 2025 04:31:15   America/New_York


    Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Rhythm Pharmaceuticals, Inc.
    Read more...
分享